bioAffinity Technologies works with University of Texas Health Science Center on its breakthrough diagnostic test CyPath that detects cancer at early stage.

Biotechnology

bioAffinity Technologies

bioAffinity Technologies' headquarters in San Antonio, TX, United States

Michael Dougherty

Vivienne I. Rebel

Timothy P. Zannes

Xavier T. Reveles

David Elzi

William Bauta

Steven Girgenti

Gary Rubin

Stuart Diamond

Robert A. Anderson

Peter S. Knight

Mohsin Y. Meghji

The Leadership Team at bioAffinity Technologies is responsible for steering the company's strategic direction and overseeing its innovative research initiatives. Comprised of top executives with expertise in research and therapeutics, the team collaborates to advance the CyPath diagnostic test, ensuring the integration of scientific discovery and business acumen to facilitate early cancer detection.

Leadership Team

The Diagnostics and Research Team at bioAffinity Technologies, comprising the Director of Diagnostics, Staff Scientist in Diagnostics, and the VP of Research, develops and optimizes the CyPath diagnostic test in collaboration with the University of Texas Health Science Center. Their work focuses on early-stage cancer detection, ensuring the accuracy, reliability, and advancement of this breakthrough technology.

Diagnostics and Research Team

��

bioAffinity Technologies

Org chart

Board & advisors

Teams

Leadership Team

Diagnostics and Research Team

Offices

��������

bioAffinity Technologies

Org chart

Board & advisors

Teams

Leadership Team

Diagnostics and Research Team

Offices

Related companies

��